Current status of Japanese HIV-infected patients with coagulation disorders: coinfection with both HIV and HCV

[1]  Jiří Zelinka,et al.  Contribution to the bandwidth choice for kernel density estimates , 2007, Comput. Stat..

[2]  J. Benito,et al.  Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy , 2007, AIDS.

[3]  D. Ho,et al.  HIV/AIDS epidemiology, pathogenesis, prevention, and treatment , 2006, The Lancet.

[4]  J. Julian,et al.  Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up. , 2006, Blood.

[5]  T. Shioda,et al.  Human genetic polymorphisms affecting HIV-1 diseases , 2006, International journal of hematology.

[6]  J. Torre-Cisneros,et al.  Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease , 2006, AIDS.

[7]  R. Greenblatt,et al.  Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984–2004 , 2005, AIDS.

[8]  D. Dieterich,et al.  Treatment of hepatitis C virus in HIV patients: a review , 2005, AIDS.

[9]  C. Sabin,et al.  Twenty five years of HIV infection in haemophilic men in Britain: an observational study , 2005, BMJ : British Medical Journal.

[10]  H. El‐Serag,et al.  Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. , 2005, Journal of hepatology.

[11]  J. Wilde,et al.  HIV and HCV coinfection in haemophilia , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[12]  S. Pérez-Hoyos,et al.  Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20 years , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[13]  S. Tatsunami,et al.  Prevalence of Hepatitis C Virus Infection in Coagulation Disorders in Japan , 2003, International journal of hematology.

[14]  Kaneo Yamada,et al.  The Number of People in Japan with Coagulation Disorders: 2001 Update , 2003, International journal of hematology.

[15]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[16]  G. Dusheiko,et al.  The natural history and antiviral treatment of hepatitis C in haemophilia , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  P. Debré,et al.  Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load. , 2002, The Journal of infectious diseases.

[18]  S. Tatsunami,et al.  Observed decline in the rate of death among Japanese hemophiliacs infected with HIV-1. , 2000, International journal of hematology.

[19]  S. Tatsunami,et al.  [Causes of death (1983-1997) in patients infected with human immunodeficiency virus by contaminated blood coagulation factor products: report of the clinical study group on prevention and treatments of HIV infection]. , 1999, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[20]  K Fukutake,et al.  Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Rowland-Jones.  Survival with HIV infection: good luck or good breeding? , 1998, Trends in genetics : TIG.

[22]  S. Darby,et al.  Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C , 1997, The Lancet.

[23]  J J Goedert,et al.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.

[24]  J. Klein,et al.  Survival Analysis: Techniques for Censored and Truncated Data , 1997 .

[25]  A. Muñoz,et al.  Models for the incubation of AIDS and variations according to age and period. , 1996, Statistics in medicine.

[26]  M. Schechter,et al.  Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters , 1996, AIDS.

[27]  P. Veugelers,et al.  The epidemiology of HIV‐associated Kaposi's sarcoma: the unraveling mystery , 1996, AIDS.

[28]  C. Sabin,et al.  CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up. , 1993, AIDS.

[29]  K. Yamada.  Pathological status and therapy of HIV-infected hemophiliacs in Japan. , 1992, The Southeast Asian journal of tropical medicine and public health.

[30]  J. Goedert,et al.  A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. , 1989, The New England journal of medicine.

[31]  Rupert G. Miller,et al.  Survival Analysis , 2022, The SAGE Encyclopedia of Research Design.